PITTSBURGH, Dec. 10, 2020 /PRNewswire/
-- Viatris Inc. (NASDAQ: VTRS) will present at the J.P.
Morgan 39th Annual Healthcare Conference on Thursday, January 14, 2021. Michael Goettler, chief executive officer, will
make a formal presentation about the company at 7:30 a.m. ET.
Investors and the general public are invited to listen to a live
webcast of the presentation at investor.viatris.com. An archived
version also will be available following the live presentation and
can be accessed at the same location for a limited time.
Viatris also announced that it will hold its inaugural Investor
Day virtually on Monday, March 1,
2021. Several members of the leadership team will present a
deep dive into the Company's strategy to deliver long-term value to
shareholders, as well as details about Viatris' Global Healthcare
Gateway™. Viatris also intends to initiate and discuss its
financial guidance for fiscal year 2021.
Interested parties will be able to access a live webcast of the
Investor Day event via the investor relations section of Viatris'
website at investor.viatris.com, with materials available at the
start of the webcast. A replay and archived edition of the
presentation will be available following the event.
About Viatris
Viatris Inc. (NASDAQ: VTRS) is a new kind of healthcare
company, empowering people worldwide to live healthier at every
stage of life. We provide access to medicines, advance
sustainable operations, develop
innovative solutions and leverage our
collective expertise to connect more people to more
products and services through our one-of-a-kind Global
Healthcare Gateway™. Formed in November 2020 through the combination of Mylan
and Pfizer's Upjohn business, Viatris brings together
scientific, manufacturing and distribution expertise with
proven regulatory, medical and commercial capabilities to
deliver high-quality medicines to patients in more than 165
countries and territories. Viatris' portfolio comprises more
than 1,400 approved molecules across a wide range of therapeutic
areas, spanning both non-communicable and infectious diseases,
including globally recognized brands, complex generic and branded
medicines, a growing portfolio of biosimilars and a variety of
over-the-counter consumer products. With a global workforce
of approximately 45,000, Viatris is headquartered in
the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more at
viatris.com and investor.viatris.com, and connect with us on
Twitter
at @ViatrisInc, LinkedIn and YouTube.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/viatris-inc-to-present-at-the-jp-morgan-39th-annual-healthcare-conference-january-14-2021-and-will-host-its-inaugural-investor-day-march-1-2021-301190287.html
SOURCE Viatris Inc.